Sickle cell disease registry at Ain Shams University

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study builds an institutional registry for sickle cell disease at the Hematology Oncology and BMT Department, Children’s Hospital, Ain Shams University in Cairo, Egypt. It starts as a retrospective description of past cases and will continue with prospective follow-up without intervention. The registry aims to collect clinical data to understand disease patterns, outcomes, and care needs over time. No experimental treatments are implemented through this registry. Participation is limited to individuals with sickle cell disease and excludes other inherited anemias, with data collected under the auspices of Ain Shams University and its clinical research center.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* children, adolescents and young adults with sickle cell disease

Exclusion Criteria:

* other inherited anemia

Where it's running

• Faculty of Medicine Ain Shams Research Institute- Clinical Research Center
  Cairo, Egypt Recruiting
• Faculty of medicine ain shams university
  Cairo, Egypt Active not recruiting

Study contacts

• Study coordinator: Dr. Fatma Ebeid Ebeid
• Email: FatmaEbeid@med.asu.edu.eg
• Phone: +20 109 5569596

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Point-of-care newborn SCD screening and early care in Côte d'Ivoire

  This trial tests whether using a Gazelle-Multispectral point-of-care test at birth plus early, comprehensive SCD care can reduce illnesses and deaths for babies with SCD in the first years of life.

  Recruiting Phase 4 Swiss Tropical & Public Health Institute · Abidjan and 1 other locations · NCT07488520

• Sickle Cell Kidney Sample Bank

  This project will collect blood and urine from adults with sickle cell disease or sickle cell trait to see if linked samples and medical records can help researchers learn how kidney disease starts and progresses.

  Recruiting at 2 sites University of Texas Southwestern Medical Center · Dallas, Texas and 1 other locations · NCT07064174

• Comparing stem cell transplantation to disease-modifying therapy for children with sickle cell disease

  This study is trying to see how well stem cell transplants work compared to other treatments for children with sickle cell disease over three years.

  Recruiting at 16 sites University of Rochester · Birmingham, Alabama and 36 other locations · NCT06941389

• Examining megakaryocytes in patients with sickle cell disease

  This study looks at how certain blood cells called megakaryocytes behave in people with sickle cell disease to see if they play a role in the complications of the illness.

  Recruiting University Hospital, Toulouse · Toulouse, France · NCT06887907

• Adjusting hydroxyurea dose using pharmacokinetics in children with sickle cell disease

  This study tests whether using pharmacokinetic testing to guide hydroxyurea dosing helps kids with sickle cell disease reach the maximum tolerated dose faster than standard blood testing alone.

  Recruiting Phase 2/3 St. Justine's Hospital · Montreal, Quebec · NCT06761560

• Depo-Provera (depot medroxyprogesterone acetate) for pain and biomarker changes in women with sickle cell disease

  This study will test whether an injectable birth control (Depo-Provera) can reduce pain in adult women with sickle cell disease.

  Recruiting Phase 4 University of Pennsylvania · Atlanta, Georgia and 1 other locations · NCT06665997

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.